Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

GMED 24.85 -0.45 (-1.78%)
price chart
Weekly CEO Sells Highlight: Globus Medical Inc, Diplomat Pharmacy Inc ...
CEO, 10% Owner of Globus Medical Inc (GMED) David C Paul sold 1,922,000 shares on 03/19/2015 at an average price of $25. Globus Medical Inc was incorporated in Delaware in March 3, 2003. Globus Medical Inc has a market cap of $2.33 billion; ...
Globus Medical Coverage Initiated by Analysts at Wells Fargo & Co. (GMED)
Globus Medical logo Equities researchers at Wells Fargo & Co. assumed coverage on shares of Globus Medical (NASDAQ:GMED) in a research report issued on Tuesday, TheFlyOnTheWall.com reports. The firm set an �outperform� rating on the stock.
Earnings of $0.25 Expected for Globus Medical, Inc. (NYSE:GMED)'s Q4  The Markets Daily
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED - Snapshot Report), reported adjusted earnings per share ("EPS") of 30 cents in the fourth quarter of 2014, beating the Zacks Consensus Estimate by 4 cents.
Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line - Analyst Blog  Nasdaq
Globus Medical Price Target Increased to $30.00 by Analysts at WallachBeth ...  The Legacy
Analysts Set Globus Medical, Inc. (NYSE:GMED) Price Target at $28.125
There are 8 research firms in total that have issued ratings on Globus Medical, Inc. (NYSE:GMED) within the past year.
Globus Medical Coverage Initiated at Wells Fargo & Co. (GMED)
Globus Medical logo Analysts at Wells Fargo & Co. initiated coverage on shares of Globus Medical (NASDAQ:GMED) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.
Is there Value for Investors: Globus Medical, Inc. (NYSE:GMED)
We look at Globus Medical, Inc. (NYSE:GMED) a company in the Healthcare industry which traders have been highly interested in of late, to assess if it provides value for investors considering buying or selling it.
First Call Rating Update on Globus Medical, Inc.
Globus Medical, Inc. (NYSE:GMED): First Call has given a rating of Strong Buy to Globus Medical, Inc., according to the information released in the research recommendation.
Globus Medical Announces the Acquisitionof Branch Medical Group, Inc.
AUDUBON, Pa., Feb 25, 2015 (BUSINESS WIRE) -- Globus Medical, Inc. GMED, -0.27% a leading musculoskeletal implant manufacturer, today announced that it has entered into an agreement to acquire Branch Medical Group, Inc. (�BMG�), a third party ...
Leerink Swann Boosts Globus Medical Price Target to $29.00 (GMED)  Dakota Financial News
Globus Medical Tanks On Lowered Guidance
Globus Medical Inc (GMED) announced its second-quarter financial results for fiscal'14 (2QFY14; ended June 30) yesterday.
Related articles »